Why assay design is critical for ultra-sensitive ddPCR cancer monitoring
Diana Vargas-Gold explains how optimized, patient-specific ddPCR assays could support ultra-sensitive liquid biopsy and minimal residual disease monitoring in laboratories




Your trusted source for online, expert-led clinical CE/CPD webinars in 2026. Watch live or on-demand at a time that suits you to stay ahead of the curve with free, accredited education designed for the modern laboratory.
Explore now